Notably, the prevailing metabolic profile of ovarian cancer patients was characterized by an apparent lack of elevated IL4I1 activity on Trp, the common substrate of IDO1, TDO and IL4I1. This evidence concerns the gene IDO1 and ovarian carcinoma.